Worldwide Life Sciences R&D AI in Clinical Trials 2025 Assessment

This document is an IDC MarketScape vendor assessment focused on the application of AI, including Generative AI (GenAI), in clinical trials within the life sciences sector for the year 2025. It outlines the critical role AI plays in transforming the life sciences industry, emphasizing the need for enterprise data readiness, use case prioritization, and change management strategies. The assessment highlights the challenges faced by technology vendors and the life sciences industry, including the rapid pace of AI evolution, the necessity for skilled personnel, and the complexities of data integration. It also discusses the importance of ethical AI practices, addressing bias, and ensuring transparency in AI decision-making. The document identifies key metrics for measuring the success of AI implementation in clinical trials, such as productivity gains and improvements in accuracy. Additionally, it provides criteria for vendor inclusion in the study, emphasizing the need for successful past implementations and substantial revenue. The assessment serves as a guide for technology buyers in the life sciences sector.